Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 8/20 | 0.64 |
| ▸ | MAOB | P27338 | 4/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | GABRP | O00591 | 3/20 | 0.45 |
| ▸ | GABRD | O14764 | 3/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.45 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.45 |
| ▸ | GABRG2 | P18507 | 3/20 | 0.45 |
| ▸ | GABRB3 | P28472 | 3/20 | 0.45 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.45 |
| ▸ | GABRA3 | P34903 | 3/20 | 0.45 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.45 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.45 |
| ▸ | GABRA4 | P48169 | 3/20 | 0.45 |
| ▸ | GABRE | P78334 | 3/20 | 0.45 |
| ▸ | GABRA6 | Q16445 | 3/20 | 0.45 |
| ▸ | GABRG1 | Q8N1C3 | 3/20 | 0.45 |
| ▸ | GABRG3 | Q99928 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28702769 | 0.84 | APP (0.63) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL22694534 | 0.84 | APP (0.59) | APPMAOBESR1ESR2NPC1 | |
| SCHEMBL3204567 | 0.81 | APP (0.50) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL735803 | 0.79 | MAOB (0.71) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL9947476 | 0.79 | MAOB (0.71) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL14390013 | 0.78 | APP (0.68) | APPMAOBESR1ESR2NPC1 | |
| SCHEMBL16317462 | 0.78 | APP (0.68) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL734887 | 0.76 | APP (0.61) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL11851368 | 0.76 | MAOB (0.61) | APPMAOBMAOAESR1ESR2 | |
| SCHEMBL734509 | 0.76 | ESR1 (0.80) | APPMAOBMAOAESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120189545-A1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS | UNIVERSITY OF PITTSBURGH -- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2012-07-26 | — | — | US | disclosed |
| US-20120148494-A1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS | UNIVERSITY OF PITTSBURGH -- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2012-06-14 | — | — | US | disclosed |
| US-8138360-B2 | substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2012-03-20 | — | — | US | disclosed |
| US-8138360-B2 | substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2012-03-20 | — | — | US | disclosed |
| EP-1945622-B1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGINGAGENTS FOR AMYLOIDOGENIC PROTEINS | UNIV PITTSBURGH (US) | 2011-12-28 | — | — | EP | disclosed |
| US-20080274058-A1 | Isotopically-Labeled Benzofuran Compounds as Imaging Agents for Amyloidogenic Proteins | UNIVERSITY OF PITTSBURGH- OF COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2008-11-06 | — | — | US | disclosed |
| US-20080274058-A1 | Isotopically-Labeled Benzofuran Compounds as Imaging Agents for Amyloidogenic Proteins | UNIVERSITY OF PITTSBURGH- OF COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2008-11-06 | — | — | US | disclosed |
| WO-2007047204-A1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGINGAGENTS FORAMYLOIDOGENIC PROTEINS | UNIVERSITY OF PITTSBURGH (US) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120148494-A1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS | BACE1, APP, BACE2 | APP 2/4885MAOB 1812/4885MAOA 2440/4885 |
| US-20080274058-A1 | Isotopically-Labeled Benzofuran Compounds as Imaging Agents for Amyloidogenic Proteins | BACE1, APP, BACE2 | APP 2/4885MAOB 1693/4885MAOA 2032/4885 |
| US-20120189545-A1 | ISOTOPICALLY-LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS | BACE1, APP, BACE2 | APP 2/4885MAOB 1693/4885MAOA 2032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.